Invention Grant
- Patent Title: Azetidine and cyclobutane derivatives as JAK inhibitors
- Patent Title (中): 氮杂环丁烷和环丁烷衍生物作为JAK抑制剂
-
Application No.: US13315750Application Date: 2011-12-09
-
Publication No.: US08420629B2Publication Date: 2013-04-16
- Inventor: James D. Rodgers , Stacey Shepard
- Applicant: James D. Rodgers , Stacey Shepard
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agent James J. Sales
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/397 ; A61P19/02
Abstract:
The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
Public/Granted literature
- US20120077798A1 AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS Public/Granted day:2012-03-29
Information query
